Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hamann

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Nature Immunology|March 23, 2001
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stockM D Hazenberg, D Hamann, H Schuitemaker, et al.
Klinische Wochenschrift|October 2, 1991
[Familial panhypopituitarism]D Hamann, T Olbricht, B P Hauffa, et al.
The Australasian Journal of Dermatology|February 1, 1997
Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent hostI D Hamann, R J Gillespie, J K Ferguson
Allergie Und Immunologie|January 1, 1991
[Characterization of a T-cell subpopulation with a new monoclonal antibody BL-TSub/2]D Hamann, H Kupper, W Eichler, et al.
Hybridoma|February 1, 1996
Conformational changes in CD45 upon monoclonal antibody crosslinkingD Hamann, W Eichler, H Fiebig, et al.
Blood|November 1, 1996
Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoformsD Hamann, P A Baars, B Hooibrink, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 1999
Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?K Peters, R Mücke, D Hamann, et al.
Radiobiologia, Radiotherapia|January 1, 1976
[On telecoblat therapy for oesophagus carcinoma (author's transl)]K H Kittner, C Lange, P G Ziegler, et al.
Radiobiologia, Radiotherapia|January 1, 1976
[Telecobalt therapy of melted bronchial carcinomas (author's transl)]D Hamann, I Rogge, K H Kittner, et al.
Waste Management (New York, N.Y.)|January 17, 2018
High voltage fragmentation of composites from secondary raw materials - Potential and limitationsT Leißner, D Hamann, L Wuschke, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Nature Immunology|March 23, 2001
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stockM D Hazenberg, D Hamann, H Schuitemaker, et al.
Klinische Wochenschrift|October 2, 1991
[Familial panhypopituitarism]D Hamann, T Olbricht, B P Hauffa, et al.
The Australasian Journal of Dermatology|February 1, 1997
Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent hostI D Hamann, R J Gillespie, J K Ferguson
Allergie Und Immunologie|January 1, 1991
[Characterization of a T-cell subpopulation with a new monoclonal antibody BL-TSub/2]D Hamann, H Kupper, W Eichler, et al.
Hybridoma|February 1, 1996
Conformational changes in CD45 upon monoclonal antibody crosslinkingD Hamann, W Eichler, H Fiebig, et al.
Blood|November 1, 1996
Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoformsD Hamann, P A Baars, B Hooibrink, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 1999
Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?K Peters, R Mücke, D Hamann, et al.
Radiobiologia, Radiotherapia|January 1, 1976
[On telecoblat therapy for oesophagus carcinoma (author's transl)]K H Kittner, C Lange, P G Ziegler, et al.
Radiobiologia, Radiotherapia|January 1, 1976
[Telecobalt therapy of melted bronchial carcinomas (author's transl)]D Hamann, I Rogge, K H Kittner, et al.
Waste Management (New York, N.Y.)|January 17, 2018
High voltage fragmentation of composites from secondary raw materials - Potential and limitationsT Leißner, D Hamann, L Wuschke, et al.
Pageof 8